Noema Pharma

About Noema Pharma

Noema Pharma is a clinical-stage biotech company focused on developing transformative therapies for conditions of the brain and nervous system, aiming to help both orphan and larger patient populations live their lives to the fullest.

Products & Services

Clinical-Stage Therapeutics:Therapies targeting CNS-mediated diseases including Severe Pain in Trigeminal Neuralgia, Involuntary Tics associated with Tourette Syndrome, Childhood Onset Fluency Disorder, and Vasomotor Symptoms (VMS) and additional symptoms of menopause.

Specialties

CNS-mediated conditions Rare neurological disorders Therapeutics for brain and nervous system disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B extension T: - FT: Series B extension	A: 147000000 MR: - FA: CHF 130 million FAN: 147000000	D: 2024-12-11 FD: 2024-12-11	8 investors
2	RT: Series B T: - FT: Series B	A: 112000000 MR: - FA: CHF 103 million FAN: 112000000	D: 2023-03-07 FD: 2023-03-07	7 investors

Series B extension Latest

2024-12-11

$147.0M

8 investors (Pro only)

Series B 2023-03-07

$112.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ilise Lombardo

Chief Executive Officer

V

Volker Knappertz

Executive Vice President of Research & Development

M

Michael Samar

Chief Financial Officer

R

Rob Lasser

Chief Medical Officer

S

Sally Nixon

Head of Operations

M

Michel David

VP CMC & Clinical Supply

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Noema Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised